Evidence map›Paper›PMID 36645791›Full record

ArticleBMJ paediatrics open2022

Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity.

Eva Miranda Marwali, Aria Kekalih, Saptadi Yuliarto, Dyah Kanya Wati, Muhammad Rayhan, Ivy Cerelia Valerie, Hwa Jin Cho, Waasila Jassat, Lucille Blumberg, Maureen Masha and 17 more

Open access · diamondAbstract read
In one paragraph

Article in BMJ paediatrics open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 17 institutions in 9 countries.

Eva Miranda MarwaliDepartment of Pediatric Cardiac Intensive Care, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia eva.marwali@pjnhk.go.id.ORCID 0000-0002-0135-536X
Aria KekalihDepartment of Community Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Saptadi YuliartoDepartment of Pediatrics, Faculty of Medicine, Universitas Brawijaya, Saiful Anwar Hospital, Malang, Jawa Timur, Indonesia.
Dyah Kanya WatiDepartment of Pediatrics, Faculty of Medicine, Universitas Udayana, Sanglah Hospital, Denpasar, Bali, Indonesia.
Muhammad RayhanDepartment of Pediatric Cardiac Intensive Care, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
Ivy Cerelia ValerieDepartment of Pediatrics, Faculty of Medicine, Universitas Udayana, Sanglah Hospital, Denpasar, Bali, Indonesia.
Hwa Jin ChoDivision of Pediatric Cardiology and Pediatric Intensive Care, Department of Pediatrics, Chonnam National University Hospital, Gwangju, Korea (the Republic of).
Waasila JassatNational Institute for Communicable Diseases, Johannesburg, South Africa.
Lucille BlumbergNational Institute for Communicable Diseases, Johannesburg, South Africa.
Maureen MashaNational Institute for Communicable Diseases, Johannesburg, South Africa.
Calum SempleInternational Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Olivia V SwannCentre for Medical Informatics, The University of Edinburgh Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.
Malte Kohns VasconcelosCentre for Neonatal and Paediatric Infection, St George's University of London, London, UK.ORCID 0000-0002-6207-9442
Jolanta PopielskaWarsaw's Hospital for Infectious Diseases, Medical University of Warsaw, Warszawa, Mazowieckie, Poland.
Srinivas MurthyDepartment of Pediatrics, Division of Critical Care, The University of British Columbia, Vancouver, British Columbia, Canada.
Robert A FowlerInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
Anne-Marie GuerguerianDepartment of Critical Care Medicine, Neurosciences and Mental Health Program, Faculty of Medicine, University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada.
Anca Streinu-CercelNational Institute of Infectious Diseases Prof Dr Matei Bals, Bucuresti, Romania.
Mohan Dass PathmanathanNational Institutes of Health, Ministry of Health Malaysia, Putrajaya, Wilayah Persekutuan, Malaysia.
Amanda RojekInternational Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Christiana KartsonakiInternational Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Bronner P GonçalvesInternational Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Barbara Wanjiru CitarellaInternational Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.ORCID 0000-0001-8968-0708
Laura MersonInternational Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Piero L OlliaroInternational Severe Acute Respiratory and emerging Infection Consortium (ISARIC), Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Heidi Jean DaltonInova Fairfax Medical Center, Inova, Falls Church, Arizona, USA.
International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) Clinical Characterization Group Investigators
University of Oxford · GBNational Institute for Communicable DiseasesUdayana University · IDUniversity of Toronto · CAChonnam National University Hospital · KRInova Fairfax Hospital · USMedical University of Warsaw · PLMinistry of Health · MYNational Brain Centre · IDNational Institute of Research and Development for Biological Sciences · ROSt George's, University of London · GBThe Royal Melbourne Hospital · AUUniversity of Brawijaya · IDUniversity of British Columbia · CAUniversity of Edinburgh · GBUniversity of Indonesia · IDUniversity of Liverpool · GB

Funding

Medical Research Council MC_PC_19059Medical Research Council MR/S032304/1Wellcome TrustWellcome Trust 215091/Z/18/ZWellcome Trust 220757/Z/20/ZWellcome Trust 222410/Z/21/ZWellcome Trust 225288/Z/22/Z
6 · The paper itself

Abstract

backgroundThe impact of the COVID-19 pandemic on paediatric populations varied between high-income countries (HICs) versus low-income to middle-income countries (LMICs). We sought to investigate differences in paediatric clinical outcomes and identify factors contributing to disparity between countries.

methodsThe International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) COVID-19 database was queried to include children under 19 years of age admitted to hospital from January 2020 to April 2021 with suspected or confirmed COVID-19 diagnosis. Univariate and multivariable analysis of contributing factors for mortality were assessed by country group (HICs vs LMICs) as defined by the World Bank criteria.

resultsA total of 12 860 children (3819 from 21 HICs and 9041 from 15 LMICs) participated in this study. Of these, 8961 were laboratory-confirmed and 3899 suspected COVID-19 cases. About 52% of LMICs children were black, and more than 40% were infants and adolescent. Overall in-hospital mortality rate (95% CI) was 3.3% [=(3.0% to 3.6%), higher in LMICs than HICs (4.0% (3.6% to 4.4%) and 1.7% (1.3% to 2.1%), respectively). There were significant differences between country income groups in intervention profile, with higher use of antibiotics, antivirals, corticosteroids, prone positioning, high flow nasal cannula, non-invasive and invasive mechanical ventilation in HICs. Out of the 439 mechanically ventilated children, mortality occurred in 106 (24.1%) subjects, which was higher in LMICs than HICs (89 (43.6%) vs 17 (7.2%) respectively). Pre-existing infectious comorbidities (tuberculosis and HIV) and some complications (bacterial pneumonia, acute respiratory distress syndrome and myocarditis) were significantly higher in LMICs compared with HICs. On multivariable analysis, LMIC as country income group was associated with increased risk of mortality (adjusted HR 4.73 (3.16 to 7.10)).

conclusionMortality and morbidities were higher in LMICs than HICs, and it may be attributable to differences in patient demographics, complications and access to supportive and treatment modalities.

Indexed as

COVID-19TuberculosisAdolescentChildCOVID-19 TestingHealth ResourcesHumansPandemicsAdolescent HealthCOVID-19Health services researchMortalityNeonatology

Identifiers

PMID36645791
PMCPMC9621167
OpenAlexW4307639193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.